Intraparenchymal chordoid Meningioma After Radiotherapy for Hodgkin Lymphoma: A Case Report and Review of the Literatur


  • Mustafa Efendioglu Dr. Lutfi Kirdar Kartal Training and Research Hospital, Department of Neurosurgery, Istanbul, Turkey
  • Recep Basaran Dr. Lutfi Kirdar Kartal Training and Research Hospital, Department of Neurosurgery, Istanbul, Turkey
  • Dogan Gundogan Istanbul Medeniyet University Goztepe Education and Research Hospital, Department of Neurosurgery, Istanbul, Turkey
  • Fatih Han Bolukbasi Medipol University School of Medicine, Department of Neurosurgery, Istanbul, Turkey
  • Mustafa Kaksi Yalova Hospital, Department of Neurosurgery, Yalova, Turkey
  • Aydin Sav Acibadem University School of Medicine Department of Pathology, Istanbul, Turkey
  • Tuncay Kaner Istanbul Medeniyet University Goztepe Education and Research Hospital, Department of Neurosurgery, Istanbul, Turkey



Meningioma, Hodgkin lymphoma, radiation, secondary tumor, chordoid, intraparenchymal.


Objective: Hodgkin lymphoma can be treated by radiotherapy or chemotherapy alone or combined. Meningiomas account for 1-4.2% of all primary intracranial tumors in children, and chordoid meningioma is a very rare subtype. In this study, we investigated a case of an intraparenchymal chordoid meningioma that developed during the early stage in a patient with Hodgkin lymphoma who had been treated with radiotherapy. Case: A 10-year-old male patient was diagnosed with Hodgkin lymphoma and was treated with a combination of radiotherapy and chemotherapy. He presented at our emergency service 6 years later. He had a fever and was suffering from discomfort and insignificant left hemiparesis (4/5). Contrast-enhanced cranial magnetic resonance imaging (MRI) showed a mass in the right temporoparietal region. The intracranial lesion was surgically excised. The tumor was identified as a WHO grade 2 chordoid meningioma by the pathological examination. The Ki-67 proliferation index was found to be 20-25%. Conclusion: Surgeons must remember that radiation-associated meningiomas may occur in the early stage of the treatment as well as in the late stage. Young patients with grade 2 chordoid meningiomas must be followed-up in case of recurrence, and tumors with high Ki-67 indexes are highly expected to relapse.


Rosen PJ, Lavey RS, Haskell CM: Hodgkin’s Disease; in Haskell CM (ed): Cancer treatment, 4th ed. Philadelphia, W.B. Saunder Company, 1995; pp. 951-979.

DeVita VT, Mauch PM, Harris NL. Hodgkin’s Disease; in DeVita VT, Hellman S, Rosenberg SA (eds): Cancer Principles and Practice of Oncology, 5th ed. Philadelphia, Lippincoltt-Raven, 1997; pp. 2242-2283.

Stein RS. Hodgkin’s Disease; in Lee RG, Foerster J, Lukens J et al. (eds). Wintrobe’s Clinical Hematology. 10th ed. Egypt, Mass Pub, 1999; pp. 2538-2571.

Horning JH. Hodgkin Lymphoma; in Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U (eds), Williams Hematology, 6th ed. McGraw-hill, 2001; pp. 1215-1235.

Bernhards J, Fischer R, Hubner K, Schwarze EW, Georgii A. Histopatological classification of Hodgkin’s lymphoma. Results from the reference pathology of the German Hodgkin’s trial. Annals of Oncology 1992; 3(4): 31-33.

Thomas RK, Re D, Zander T, Wolf J, Diehl V. Epidemiology and etiology of Hodgkin’s lymphoma. ESMO 2002; 147-152.

Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001.).

Altuntas F, Eser B, Kaplan B, Canoz O, Gundogan K, Ozkan M, et al. Hodgkin hastalarında ilk basamak tedavi sonucları: tek merkez deneyimi. THOD 2003; 2(13): 79-86.

Ekstrand BC, Lucas JB, Horwitz SM, Fan Z, Breslin S, Hoppe RT, et al. Rituximab in lymphocyte predominant Hodgkin’s disease: results of a Phase II Trial. Blood 2003; 101: 4285-4289.

Rehwald U, Schulz H, Reiser M, Sieber M, Staak JO, Morschhauser F, et al. Treatment of relapsed CD20+ Hodgkin lymphoma with the monoclonal antibody rituximab is effective and well tolerated: results of a phase 2 trial of the German Hodgkin Lymphoma Study Group. Blood 2003; 101(2): 420-424.

Diehl V, Franklin J, Hasenclever D, Tesch H, Pfreundschuh M, Lathan B, et al. BEACOPP, a new dose escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced stage Hodgkin’s lymphoma: interim report from a trial of the German Hodgkin’s Lymphoma Study Group. Ann Oncol 1997; 8: 143.

Nissen N, Nordentoft A. Radiotherapy versus combined modality treatment of stage I and II Hodgkin’s disease. Cancer Tret Rep 1982; 66: 799-803.

Dores GM, Metayer C, Curtis RE, Lynch CF, Clarke EA, Glimelius B, et al. Second malignant neoplasmsamong long-termsurvivors ofHodgkin’s disease: a population-based evaluation over 25 years. J Clin Oncol 2002; 20: 3484-94.

Green DM, Hyland A, Barcos MP, Reynolds JA, Lee RJ, Hall BC, et al. Second malignant neoplasmsafter treatment forHodgkin’s disease in childhood or adolescence. J Clin Oncol 2000; 18: 1492-9.

Aleman BM, van den Belt-Dusebout AW, Klokman WJ, Van’t VeerMB, BartelinkH, vanLeeuwenFE. Long-termcause-specific mortality of patients treated for Hodgkin’s disease. J Clin Oncol 2003; 21: 3431-9.

Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, et al. Childhood Cancer Survivor. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006; 355: 1572-82.

Amirjamshidi A, Mehrazin M, Abbassioun K. Meningiomas of the central nervous system occurring below the age of 17: report of 24 cases not associated with neurofibromatosis and review of literature. Childs Nerv Syst 2000; 16: 406-416.

Deen HG Jr, Scheithauer BW, Ebersold MJ. Clinical and pathological study of meningiomas of the first two decades of life. J Neurosurg 1982; 56: 317-322.

Drake JM, Hendrick EB, Becker LE, Chuang SH, Hoffman HJ, Humphreys RP. Intracranial meningiomas in children. Pediatr Neurosci 1985-1986; 12: 134-139.

Emoto S, Okada H, Hayami T. Subcortical meningioma: Report of a case of successful removal. Nihon Geka Hokan 1954; 23: 397-400.

Ferrante L, Acqui M, Artico M, Mastronardi L, Rocchi G, Fortuna A. Cerebral meningiomas in children. Childs Nerv Syst 1989; 5: 83-86.

Germano IM, Edwards MS, Davis RL, Schiffer D. Intracranial meningiomas of the first two decades of life. J Neurosurg 1994; 80: 447-453.

Herz DA, Shapiro K, Shulman K. Intracranial meningiomas in infancy, childhood and adolescence. Review of the literature and addition of 9 case reports. Childs Brain 1980; 7: 43-56.

Menon G, Nair S, Sudhir J, Rao BR, Mathew A, Bahuleyan B. Childhood and adolescent meningiomas: a report of 38 cases and review of literature. Acta Neurochir (Wien) 2009; 151: 239-244.

Rochat P, Johannesen HH, Gjerris F. Long-term follow up of children with meningiomas in Denmark: 1935 to 1984. J Neurosurg 100(2 Suppl Pediatrics) 2004; 179-182.

Rushing EJ, Olsen C, Mena H, Rueda ME, Lee YS, Keating RF, et al. Central nervous system meningiomas in the first two decades of life: a clinicopathological analysis of 87 patients. J Neurosurg 2005; 103(6 Suppl): 489-495.

Sandberg DI, Edgar MA, Resch L, Rutka JT, Becker LE, Souweidane MM. MIB-1 staining index of pediatric meningiomas. Neurosurgery 2001; 48: 590-597.

Suematsu K, Tokuda S, Miyazaki Y. Intracranial Meningioma in a five-month-old infant: A case report and review of the literature. No To Shinkei 1974; 26: 453-464 (Japanese).

Cushing H, Eisenhardt L. Meningiomas Without Dural Attachment. Springfield, Illinois, Charles C Thomas, 1938; pp. 133-168.

Couce ME, Aker FV, Scheithauer BW. Chordoid meningioma: A clinicopathologic study of 42 cases. Am J Surg Pathol 2000; 24: 899-905.

Mullassery D, O’Brien DF, Williams D, Crooks D, Mallucci C, Pizer B, et al. Malignant disseminated chordoid meningioma in a 12-year-old child: a role for early cranial and spinal radiation treatment after subtotal resection. Child’s Nerv Syst 2006; 22: 1344-1350.

Walter AW, Hancock ML, Pui CH, Hudson MM, Ochs JS, Rivera GK, et al. Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children’s Research Hospital. J Clin Oncol 1998; 16: 3761-3767.

Neglia JP, Robison LL, Stovall M, Liu Y, Packer RJ, Hammond S, et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2006; 98: 1528-1537.

Kohama I, Sohma T, Nunomura K, Igarashi K, Ishikawa A. Intraparenchymal meningioma in an infant—case report. Neurol Med Chir (Tokyo) 1996; 36: 598-601.

Legius E, Vles JS, Casaer P, Plets C, Dom R. Intraparenchymal meningioma in a 14-month-old infant: case report. Brain Dev 1985; 7: 622-624.

Deutsch M, Rosenstein M, Figura JH. Meningioma after radiotherapy for Hodgkin's disease. Am J Clin Oncol 1999; 22(4): 361-3.

Engert A, Diehl V, Franklin J, hri A, Dörken B, Ludwig WD, et al. Escalateddose BEACOPP in the treatment of patients with advanced-stage Hodgkin’s lymphoma: 10 years of follow-up of the GHSG HD9 study. J Clin Oncol 2009; 27(27): 4548-4554.

Bjo¨rkholm M, Holm G, Mellstedt H. Immunocompetence in patients with Hodgkin’s disease; in Lacher M, Redman J, (eds): Consequences of Survival in Hodgkin’s Disease. New York, NY, Lea &Febiger, 1990; pp. 112-150.

van Leeuwen FE, Chorus AM, van den Belt-Dusebout AW, Hagenbeek A, Noyon R, van Kerkhoff EH, et al. Leukemia risk following Hodgkin’s disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage. J Clin Oncol 1994; 12(5): 1063-1073.

Hoppe RT. Hodgkin’s disease: complications of therapy and excess mortality. Ann Oncol. 1997; 8 Suppl 1: 115-118.

Salloum E, Jillella AP, Nadkarni R, Seropian S, Hu GL, D'Andrea E, et al. Assessment of pulmonary and cardiac function after high dose chemotherapy with BEAM and peripheral blood progenitor cell transplantation. Cancer. 1998; 82(8): 1506-1512.<1506::AID-CNCR12>3.0.CO;2-8

van Leeuwen F, Swerdlow A, Valagussa P, et al. Second cancers after treatment of Hodgkin’s disease; in Mauch PM, Armitage JO, Diehl V, et al, eds: Hodgkin’s Disease. Philadelphia, PA, Lippincott Williams & Wilkins, 1999; pp. 607-632.

Swerdlow AJ, Barber JA, Hudson GV, Cunningham D, Gupta RK, Hancock BW, et al. Risk of second malignancy after Hodgkin’s disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol 2000; 18(3): 498-509.

Ng AK, Bernardo MP, Weller E, Backstrand KH, Silver B, Marcus KC, et al. Long-term survival and competing causes of death in patients with early-stage Hodgkin’s disease treated at age 50 or younger. J Clin Oncol 2002; 20(8): 2101-2108.

Adams MJ, Lipsitz SR, Colan SD, Tarbell NJ, Treves ST, Diller L, et al. Cardiovascular status in long-term survivors of Hodgkin’s disease treated with chest radiotherapy. J Clin Oncol 2004; 22(15): 3139-3148.

Landgren O, Bjo¨rkholm M, Konradsen H, Söderqvist M, Nilsson B, Gustavsson A, et al. A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin’s lymphoma. J Internal Med 2004; 255(6): 664-673.

Chow LM, Nathan PC, Hodgson DC, Jenkin D, Weitzman S, Grant RM, et al. Survival and late effects in children with Hodgkin’s lymphoma treated with MOPP/ABV and lowdose, extended-field irradiation. J Clin Oncol 2006; 24(36): 5735-5741.

Swerdlow AJ, Higgins CD, Smith P, Cunningham D, Hancock BW, Horwich A, et al. Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. J Natl Cancer Inst 2007; 99(3): 206-214.

Heidenreich PA, Schnittger I, Strauss HW, Vagelos RH, Lee BK, Mariscal CS, et al. Screening for coronary artery disease after mediastinal irradiation for Hodgkin’s disease. J Clin Oncol 2007; 25(1): 43-49.

De Bruin ML, Dorresteijn LDA, van’t Veer MB, Krol AD, van der Pal HJ, Kappelle AC, et al. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma. J Natl Cancer Inst 2009; 101(13): 928-937.

Straus DJ. Chemotherapy only for localized Hodgkin lymphoma. J Intern Med 2011: 270(3): 197-205.

Cahan WG, Woodard HQ, Higinbotham NL, Stewart FW, Coley BL. Sarcoma arising in irradiated bone: report of eleven cases. Cancer 1948; 1: 3-29.<3::AID-CNCR2820010103>3.0.CO;2-7

Liwnicz BH, Berger TS, Liwnicz RG, Aron BS. Radiation-associated gliomas: a report of four cases and analysis of postradiation tumors. Neurosurgery 1985; 17(3): 436-45.

Mann I, Yates PC, Ainslie JP. Unusual case of double primary orbital tumor. Br J Ophthalmol 1953; 37: 758-762.

Behringer K, Josting A, Schiller P, Eich HT, Bredenfeld H, Diehl V, et al. German Hodgkin Lymphoma Study Group. Solid tumors in patients treated for Hodgkin's disease: a report from the German Hodgkin Lymphoma Study Group. Ann Oncol 2004 Jul; 15(7): 1079-85.

Clifton MD, Amromin GD, Perry MC, Abadir R, Watts C, Levy N. Spinal cord glioma following irradiation for Hodgkin’s disease. Cancer 1980; 45: 2051-2005.<2051::AID-CNCR2820450811>3.0.CO;2-3

Schmitt K, Tulzer W. Second tumor following Hodgkin's disease. Padiatr Padol 1984; 19(3): 259-62.

Takaue Y, Sullivan MP, Ramirez I, Cleary KR, van Eys J. Second malignant neoplasm in treated Hodgkin's disease. Report of a patient and scope of the problem. Am J Dis Child 1986; 140(1): 49-51.

Bazan C, New PZ, Kagan-Hallet KS. MRI of radiation induced spinal cord glioma. Neuroradiology 1990; 32: 331-333.

Martin AJ, Hammond CJ, Dobbs HJ, Al-Sarraj S, Thomas NW. Spinal meningioma after treatment for Hodgkin disease. Case report. J Neurosurg 2001; 95(2 Suppl): 232-5.

Riffaud L, Bernard M, Lesimple T, Morandi X. Radiation-induced spinal cord glioma subsequent to treatment of Hodgkin’s disease: case report and review. Journal of Neuro-Oncology 2006; 76: 207-211.

Ng C, Fairhall J, Rathmalgoda C, Stening W, Smee R. Spinal cord glioblastoma multiforme induced by radiation after treatment for Hodgkin disease. Case report. J Neurosurg Spine 2007; 6(4): 364-7.

Banerjee J, Pääkkö E, Harila M, Herva R, Tuominen J, Koivula A, et al. Radiation-induced meningiomas: a shadow in the success story of childhood leukemia. Neuro Oncol 2009; 11(5): 543-9.

Strojan P, Popovic M, Jereb B. Secondary intracranial meningiomas after high-dose cranial irradiation: report of five cases and review of the literature. Int J Radiat Oncol Biol Phys 2000; 48: 65-73.

Iacono RP, Apuzzo MLJ, Davis RL, Tsai FY. Multiple meningiomas following radiation therapy for medulloblastoma. J Neurosurg 1981; 55: 282-6.

Deutsch M. Meningioma; in Deutsch M, ed: Management of childhood brain tumors. Boston, Kluwer Academic Publishers, 1990; pp. 357-68.

Hawkins MM, Draper GJ, Kingston JE. Incidence of second primary tumours among childhood cancer survivors. Br J Cancer 1987; 56: 339-47.

Bhatia S, Robison LL, Oberlin O, Greenberg M, Bunin G, Fossati-Bellani F, et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Eng J Med 1996; 334: 745-50.

Meadows AT, Baum E, Fossati-Bellani F, Green D, Jenkin RD, Marsden B, et al. Second malignant neoplasms in children: an update from the late effects study group. J Clin Oncol 1985; 3: 532-8.

Wolden SL, Lamborn KR, Cleary SF, Tate DJ, Donaldson SS. Second cancers following pediatric Hodgkin's disease. J Clin Oncol 1998; 16: 536-44.

Baccarani M, Bosi A, Papa G. Second malignancy in patients treated for Hodgkin's disease. Cancer 1980; 46: 1735-40.<1735::AID-CNCR2820460806>3.0.CO;2-3

Swerdlow AJ, Douglas AJ, Vaughan Hudson G, Vaughan Hudson B, MacLennan KA. Risk of second primary cancer after Hodgkin's disease in patients in the British National Lymphoma Investigation: relationships to host factors, histology and stage of Hodgkin's disease, and splenectomy. Br J Cancer 1993; 68: 1006-11.

Prior P, Pope DJ. Hodgkin's disease: subsequent primary cancers in relation to treatment. Br J Cancer 1988; 58: 512-7.

Kushner BH, Zauber A, Tan CTC. Second malignancies after childhood Hodgkin's disease. Cancer 1988; 62: 1364-70.<1364::AID-CNCR2820620721>3.0.CO;2-T

Lin HM, Teitell MA. Second malignancy after treatment of pediatric Hodgkin disease. J Pediatr Hematol Oncol 2005; 27(1): 28-36.

Cushing H, Eisenhardt L. Serial enumeration of meningiomas; in Thomas CC (ed): Meningiomas. their classification, regional behaviour, life history, and surgical end results. Thomas, Springfield, 1938; pp. 534-570.

Shimbo D, Kato T, Takeda M, Ikeda H. Intraparenchymal Meningioma in a Child. Neurol Med Chir (Tokyo) 2011; 51: 793-797.

Wada T, Suzuki M, Beppu T, Arai H, Yoshida Y, Ogawa A, et al. A case of subcortical meningioma. Acta (Wien) 2000; 142: 209-213.

Sano K, Wakai S, Ochiai C, Takakura K. Characteristics of intracranial meningiomas in childhood. Childs Brain 1981; 8(2): 98-106.

Schroeder BA, Samaraweera RN, Starshak RJ, Oechler HW. Intraparenchymal meningioma in a child: CT and MR findings. J Comput Assist Tomogr 1987; 11: 192-193.

Kimura H, Nakagawa A, Sakaki S, Matsuoka K. Intracranial meningioma of an infant: a case report. No Shinkei Geka 1987; 15: 663-668.

Mamourian AC, Lewandowski AE, Towfighi J. Cystic intraparenchymal meningioma in a child: case report. AJNR Am J Neuroradiol 1991; 12: 366-367.

Matsumoto M, Nakazawa K, Hashimoto T, Nakamura N. A case of meningioma in a child associated with focal motor seizure. Shoni No Noshinkei 1992; 17: 285-288.

Kaneko F, Sasaki K, Kobayashi T. Intra-axial meningioma in childhood—case report. Tokushima Shimin Byoin Igaku Zasshi 1993; 7: 131-134.

Miwa Y, Uemura, Takada M, Funaoka T, Yamada H. A case of singular meningioma in a child; in Proceedings of the 10th Congress of Japanese Pediatric Neurosurgery 1996, cited in 21.

Teo JG, Goh KY, Rosenblum MK, Muszynski CA, Epstein FJ. Intraparenchymal clear cell meningioma of the brainstem in a 2-year-old child. Case report and literature review. Pediatr Neurosurg 1998; 28: 27-30.

Karadereler S, Aker F, Berkman Z. Intraparenchymal meningioma in a child. Case report and review of the literature. J Neurosurg 2004; 101(1 Suppl): 112-115.

Zhang J, Chi LY, Meng B, Li F, Zhu SG. Meningioma without dural attachment: case report, classification, and review of the literature. Surg Neurol 2007; 67: 535-539.

Kepes JJ, Chen WY-K, Connors MH, Vogel FS. “Chordoid” meningeal tumors in young individuals with peritumoral lymphoplasmocellular infiltrates causing systemic manifestations of the Castleman syndrome. A report of seven cases. Cancer 1988; 62: 391-406.<391::AID-CNCR2820620226>3.0.CO;2-7

Epari S, Sharma MC, Sarkar C, Garg A, Gupta A, Mehta VS. Chordoid meningioma, an uncommon variant of meningioma: a clinicopathologic study of 12 cases. J Neurooncol 2006; 78: 263-269.

Kobata H, Kondo A, Iwasaki K, Kusaka H, Ito H, Sawada S. Chordoid meningioma in a child. Case report. J Neurosurg 1998; 88: 319-323.

Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002; 61: 215-225.

Kleihues P, Burger PC, Scheithauer BW. Histological typind of tumours of the central nervous system, 2nd edn. Berlin, Springer, 1993.

Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol 1993; 3: 255-268.

Marhx-Bracho A, Rueda-Franco F, Ibarra-de la Torre A, García-González O, Bornstein-Quevedo L, de León-Bogorge B. Chordoid meningioma of the foramen magnum in a child: a case report and review of the literature. Childs Nerv Syst 2008; 24: 623-627.

Song KS, Park SH, Cho BK, Wang KC, Phi JH, Kim SK. Third ventricular chordoid meningioma in a child. J Neurosurg Pediatr 2008; 2(4): 269-72.

Gold DG, Neglia JP, Dusenbery KE. Second neoplasms after megavoltage radiation for paediatric tumours. Cancer 2003; 97: 2588-2596.

Moss SD, Rockswold G, Chou SN, Yock D, Berger MS. Radiation-induced meningiomas in paediatric patients. Neurosurgery 1988; 22: 758-761.

Rusyniak WG, Marchese MJ, Nelson CN. Benign meningioma with a short latency period following irradiation. Surg Neurol 1992; 38: 261-264.

Bliss P, Kerr GR, Gregor A. Incidence of second brain tumors after pituitary irradiation in Edinburgh 1962-1990. Clin Oncol 1994; 6: 361-363.

Kano T, Zama A, Ono N, Nakamura T, Tamura M, Ohe T, et al. A juvenile case of radiation induced meningioma two years after radiation for craniopharyngioma. No Shinkei Geka 1994; 22: 367-370.

Mack EE, Wilson CB. Meningiomas induced by high-dose cranial irradiation. J Neurosurrg 1993; 79: 28-31.

Starshak RJ. Radiation-induced meningioma in children: report of two cases and review of literature. Pediatr Radiol 1996; 26: 537-541.

Duffner PK, Krischer JP, Horowitz ME, Cohen ME, Burger PC, Friedman HS, et al. Second malignancies in young children with primary brain tumors following treatment with prolonged postoperative chemotherapy and delayed irradiation: a Pediatric Oncology Group study. Ann Neurol 1998; 44: 313-316.

Caroli E, Salvati M, Roperto R, D'Andrea G, Ferrante L. High-dose radiation-induced meningioma in children - case report and critical review of the literature. Zentralbl Neurochir 2005; 66(1): 39-42.

Choudhary A, Pradhan S, Huda MF, Mohanty S, Kumar M. Radiation induced meningioma with a short latent period following high dose cranial irradiation - case report and literature review. J Neurooncol 2006; 77(1): 73-7. Epub 2005 Nov 15.

Freudenstein D, Bornemann A, Ernemann U. Intracranial malignant B-cell lymphoma of the dura. Clin Neuropathol 2000; 19: 34-37.

Katz S, J. Rootman, R. Goldberg. Secondary and metastatic tumors of the orbit. Duane's ophthalmology, Philadelphia, Lippincott Williams & Wilkins, 2007.

Brown DC, Gatter KC: Ki-67 protein: The immaculate deception? Histopathology 2002; 40: 2-11.

Kolles H, Niedermayer I, Schmitt C, Henn W, Feld R, Steudel WI, et al. Triple approach for diagnosis and grading of meningiomas: Histology, morphometry of Ki-67/Feulgen stainings, and cytogenetics. W Acta Neurochir (Wien) 1995; 137: 174-181.

Karamitopoulou E, Perentes E, Tolnay M, Probst A. Prognostic significance of MIB-1, p53 and bcl-2 immunoreactivity in meningiomas. Hum Pathol 1998; 291: 140-145.

Lanzafame S, Torrisi A, Barbagallo G, Emmanuele C, Alberio N, Albanese V. Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up. Pathol Res Pract 2000; 196: 483-438.

Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM. The prognostic signifi cance of MIB-1, p53, and DNA fl ow cytometry in completely resected primary meningiomas. Cancer 1998; 82: 2262-69.<2262::AID-CNCR23>3.0.CO;2-R

Matsuno A, Fujimaki T, Sasaki T, Nagashima T, Ide T, Asai A, et al. Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas. Acta Neuropathol 1996; 91: 504-510.

Nakasu S, Li DH, Okabe H, Nakajima M, Matsuda M. Significance of MIB-1 staining incides in meningiomas. Comprasion of two couting methods. Am J Surg Pathol 2001; 25(4): 472-478.

Maier H, Wanschitz J, Sedivy R, Rössler K, Ofner D, Budka H. Proliferation and DNA fragmentation in meningioma subtypes. Neuropathol Appl Neurobiol 1997; 23(6): 496-506.

Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC. "Malgnancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 1999; 85(9): 2046-2056.<2046::AID-CNCR23>3.0.CO;2-M

Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM. Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol 1997; 21(12): 1455-65.

Ragel B, Jensen R. Pathophysiology of meningiomas. Sem Neurosurg 2003; 14: 169-186.

Couce ME, Aker FV, Scheithauer BW. Chordoid Meningioma: A Clinicopathologic Study of 42 Cases. The American Journal of Surgical Pathology 2000; 24(7): 899-905.




How to Cite

Mustafa Efendioglu, Recep Basaran, Dogan Gundogan, Fatih Han Bolukbasi, Mustafa Kaksi, Aydin Sav, & Tuncay Kaner. (2014). Intraparenchymal chordoid Meningioma After Radiotherapy for Hodgkin Lymphoma: A Case Report and Review of the Literatur. Journal of Cancer Research Updates, 3(1),  30–41.